April Effort
, Vice President and Head of Corporate Development, Vigil Neuroscience
April Effort is Vice President and Head of Corporate Development at Vigil Neuroscience, where she leads strategy, business development, and partnering initiatives to advance the company’s neurodegenerative disease pipeline. She brings over 15 years of experience in corporate development, licensing, and company building across the life sciences sector. Before joining Vigil, April held senior corporate development roles at Allena Pharmaceuticals and worked with the Third Rock Ventures company creation and partner development teams. Earlier in her career, she led business development at Boston University’s Technology Development Office, managing a diverse portfolio of therapeutic and diagnostic technologies.
